1h Free Analyst Time
The stool testing market is forecasted to grow by USD 445.95 mn during 2023-2028, accelerating at a CAGR of 5.92% during the forecast period. The report on the stool testing market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by favorable initiatives and the increasing prevalence of gastrointestinal diseases, increasing guidelines from healthcare organizations, and increasing prevalence of CRC.
The stool testing market is segmented as below:
By Type
- GI
- Fecal occult
By End-user
- Hospitals
- Diagnostic centres and laboratories
- Clinics and others
By Geographical Landscape
- North America
- Europe
- Asia
- Rest of World (ROW)
The report on the stool testing market covers the following areas:
- Stool testing market sizing
- Stool testing market forecast
- Stool testing market industry analysis
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.
Table of Contents
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Type
7 Market Segmentation by End-user
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Trends
11 Vendor Landscape
12 Vendor Analysis
13 Appendix
List of Exhibits
Executive Summary
The publisher recognizes the following companies as the key players in the global stool testing market: AdvaCare Pharma, bioMerieux SA, Cardinal Health Inc., Cenogenics Corp., Danaher Corp., DiaSorin SpA, Eiken Chemical Co. Ltd., Epitope Diagnostics Inc., Exact Sciences Corp., Genova Diagnostics Inc., Helena Laboratories Corp., Hologic Inc., McKesson Corp., Meridian Bioscience Inc., Pinnacle BioLabs, Polymedco CDP LLC, Quest Diagnostics Inc., Quidelortho Corp., CTK Biotech Inc., and ScheBo Biotech AG.Commenting on the report, an analyst from the publisher said: 'The latest trend gaining momentum in the market is high growth potential in emerging markets.'
According to the report, one of the major drivers for this market is the favorable initiatives and the increasing prevalence of gastrointestinal diseases.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- AdvaCare Pharma
- bioMerieux SA
- Cardinal Health Inc.
- Cenogenics Corp.
- Danaher Corp.
- DiaSorin SpA
- Eiken Chemical Co. Ltd.
- Epitope Diagnostics Inc.
- Exact Sciences Corp.
- Genova Diagnostics Inc.
- Helena Laboratories Corp.
- Hologic Inc.
- McKesson Corp.
- Meridian Bioscience Inc.
- Pinnacle BioLabs
- Polymedco CDP LLC
- Quest Diagnostics Inc.
- Quidelortho Corp.
- CTK Biotech Inc.
- ScheBo Biotech AG
